Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec 28;7(2):149-152.
doi: 10.1016/j.aace.2020.12.002. eCollection 2021 Mar-Apr.

Cushing's Disease as a Result of Two ACTH-Secreting Pituitary Tumors

Affiliations
Case Reports

Cushing's Disease as a Result of Two ACTH-Secreting Pituitary Tumors

Christine Mathai et al. AACE Clin Case Rep. .

Abstract

Objective: Our objective is to present a case of Cushing's disease (CD) with 2 adrenocorticotropic hormone (ACTH)-secreting pituitary tumors. Multiple monohormonal pituitary tumors are rare. This case supports a consideration of repeat transsphenoidal surgery (TSS) in patients with initial surgical failure.

Methods: Salivary, 24-h urine, serum cortisol testing, and magnetic resonance imaging (MRI) were used to diagnose CD. Treatment included TSS and postoperative hydrocortisone.

Results: A 36-year-old woman followed for hypothyroidism presented with a new left supraclavicular fossa swelling and underwent Cushing's syndrome screening. The levels of late-night salivary cortisol were 0.636 and 0.316 μg/dL, 24-h urine cortisol was 162 μg/24 h, cortisol after 1-mg dexamethasone suppression was 14.0 μg/dL, and serum morning cortisol was 26.4 μg/dL with ACTH of 66.7 pg/mL. A 7-mm hypoenhancing anterior pituitary lesion was noted on pituitary MRI. The cortisol level was 2.7 μg/dL after an 8-mg dexamethasone suppression. She underwent TSS, and her histopathology read as pituitary adenoma staining positive for ACTH. No residual tumor was seen intraoperatively. Postoperative morning serum cortisol was 17.9 μg/dL, and ACTH level was 79 pg/mL. Repeat TSS revealed a second adenoma previously unseen on MRI, which also stained positive for ACTH. Postoperative morning cortisol was 0.7 μg/dL, and ACTH was <9 pg/mL. Hydrocortisone, which was started for her central adrenal insufficiency, was tapered and stopped 1 year postoperatively. Late-night salivary cortisol levels were 0.016 and 0.012 μg/dL.

Conclusion: We conclude that surgical failure in CD after initial TSS should warrant the consideration of a second ACTH-secreting pituitary adenoma and possible repeat TSS.

Keywords: ACTH, adrenocorticotropic hormone; ACTH-secreting pituitary adenoma; CD, Cushing’s disease; Cushing’s syndrome; MRI, magnetic resonance imaging; TSS, transsphenoidal surgery; pituitary tumors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Brain MRI with and without contrast with attention to the sella notes a microadenoma. It measures 6 × 4 mm in coronal dimension and 7 mm in AP dimension. A, coronal view and B, sagittal view
Fig. 2
Fig. 2
ACTH and cortisol levels before and after first and second TSS. Adrenocorticotropic hormone (ACTH) (pg/mL, normal range, 9-46 pg/mL), cortisol (μg/dL), transsphenoidal surgery (TSS)

Similar articles

Cited by

References

    1. Nieman L.K., Biller B.M.K., Findling J.W. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807–2831. - PMC - PubMed
    1. Burke W.T., Penn D.L., Repetti C.S. Outcomes after repeat transsphenoidal surgery for recurrent Cushing disease: updated. Neurosurgery. 2019;85(6):E1030–E1036. - PubMed
    1. Rubinstein G., Ossald A., Zopp S. Therapeutic options after surgical failure in Cushing’s disease: a critical review. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101270. - PubMed
    1. Barbot M., Zilio M., Scaroni C. Cushing’s syndrome: overview of clinical presentation, diagnostic tools and complications. Best Pract Res Clin Endocrinol Metab. 2020 Jan 30:101380. doi: 10.1016/j.beem.2020.101380. - DOI - PubMed
    1. Faggiano A., Pivonello R., Melis D. Nephrolithiasis in Cushing’s disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab. 2003;88(5):2076–2080. - PubMed

Publication types

LinkOut - more resources